Bajaj Healthcare Q1FY24 Results: Consolidated Loss of Rs. 48.21 Cr

Bajaj Healthcare Q1FY24 Results: Consolidated Loss of Rs. 48.21 Cr

Bajaj Healthcare Q1 results show revenue fell from 154.83 crores to 129.95 crores, a -16.07% decrease in growth. EPS down from ₹1.30 to ₹-17.47, down by -1443.85%.

First, Let’s Begin with Quarter-on-Quarter Basis:

Bajaj Healthcare shared its Q1 results on Monday. They earned 129.95 crores in revenue this quarter, but that’s less than the 154.83 crores they made last quarter. Unfortunately, the company’s growth decreased by -16.07 percent when comparing the two quarters.

In terms of profits, the company’s PAT (Profit After Tax) for this quarter was -48.21 crores, down from 3.59 crores in the previous quarter. Their quarter-to-quarter growth decreased by -1,442.04 percent.

The company’s EPS (Earnings Per Share) this quarter is ₹-17.47, which is a decrease of -1,443.85% from the ₹1.30 EPS in the previous quarter.

Now, Let’s Analyze the Results on a Year-over-Year Basis:

The company made a total revenue of 129.95 crores this year (2023), which is -20.98 percent lower than last year’s total revenue of 164.46 crores.

This year’s PAT (Profit After Tax) is -48.21 crores, which is also -501.13% lower than last year’s PAT of 12.01 crores.

The EPS (Earnings Per Share) for this year is ₹-17.47, which is -501.61% less than the EPS of ₹4.35 earned last year.

Also Read: GMR Airports Q1FY24 Results: Consolidated PAT of Rs. 29.80 Cr

Bajaj Healthcare Share Dividend Announcement / Record Date:

The record date for the dividend has not arrived yet.

About Bajaj Healthcare:

Bajaj Healthcare Limited operates as a pharmaceutical company based in India. The company’s primary focus lies in the production of bulk drugs and pharmaceutical products.

Download the Full PDF of Bajaj Healthcare Q1 Results: Click Here

For more of the Latest News, Click Here

Leave a Reply

Your email address will not be published. Required fields are marked *